Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ViaCyte
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ViaCyte
-
Don't forget our presentation is at 11:15 am PST today in Franciscan C (Ballroom Level).
#BTS20#BiotechShowcase#JPM2020#JPM20https://twitter.com/ViaCyte/status/1214911733514428416 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're headed to
#SanFrancisco next week, and our CEO will be presenting Monday at#BiotechShowcase More info: https://viacyte.com/press-releases/viacyte-to-present-at-biotech-showcase-2020-in-san-francisco/ …#JPM2020#JPM20#BTS20#regenmed#diabetes#T1D#regenerativemedicinepic.twitter.com/EmDTcOourX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ViaCyte wishes you a very happy holiday! Thank you for following our progress in developing a functional cure for insulin-requiring
#diabetes.#SanDiego#type1diabetes#biotech#regenerativemedicine#health#T1Dpic.twitter.com/O8ULa79BoX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ViaCyte wishes you a very happy holiday! Thank you for following our progress in developing a functional cure for insulin-requiring
#diabetes.#SanDiego#type1diabetes#biotech#regenerativemedicine#health#T1Dpic.twitter.com/87Z663UmS1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join the ViaCyte team: We are seeking a Manufacturing Technician, Executive Administrative Assistant, Facilities Mechanic, Associate Quality Control, and HR Specialist https://viacyte.com/careers/
#careers#jobs#STEMjobs#biotech#regenerativemedicine#SanDiegopic.twitter.com/P9CHgjPNI3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy Thanksgiving from ViaCyte! We are thankful for your support and for our team and collaborators who are dedicated to curing type 1 diabetes.pic.twitter.com/HvMksD1Qub
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tomorrow at 2 pm: ViaCyte’s VP, Research and CSO Kevin D’Amour to present at
#diabetes session for “From Stem Cell Biology to New Therapies” http://bit.ly/2JMgVni@ISSCR#biotech#Toronto#health#T1D#type1diabetes#regenerativemedicine#regenmed#clinicaltrialspic.twitter.com/vWwxvHYt4H
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nov. 6: ViaCyte VP, Research and CSO Kevin D’Amour to speak at
@ISSCR’s “From Stem Cell Biology to New Therapies” http://bit.ly/2JMgVni#ISSCR#biotech#Toronto#health#T1D#type1diabetes#diabetes#regenerativemedicine#regenmed#clinicaltrialspic.twitter.com/PG9SfASQZh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For more on the new ViaCyte clinical data, see the live webcast from the Cell & Gene Meeting on the Mesa today at 1:45 pm: http://bit.ly/2odeeUe
#T1D#type1diabetes#diabetes#regenmed#regenerativemedicine#Mesa19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ViaCyte presents preliminary PEC-Direct clinical data showing implanted cells, when effectively engrafted, are capable of producing circulating C-peptide, a biomarker for insulin, in patients with type 1
#diabetes: http://bit.ly/2odfjLZ#T1D#type1diabetespic.twitter.com/tlnVSRNymW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ViaCyte CEO and President Paul Laikind to present at 1:45 pm PT at the Cell & Gene Meeting on the Mesa: http://bit.ly/2mNkJfp
#Mesa19#biotech#SanDiego#health#T1D#type1diabetes#diabetes#regenerativemedicine#regenmed#clinicaltrials@alliancermpic.twitter.com/Yr1myyh37e
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ViaCyte Q&A: CRISPR Tx quick progress, ongoing diabetes trial, & more w/
@pknoepfler http://bit.ly/2mNhLrC#biotech#health#T1D#diabetes#regenerativemedicine#regenmedHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
News:
@CRISPRTX and ViaCyte present positive in vitro data towards a potential immune-evasive cell replacement therapy for#diabetes at#EASD2019: http://bit.ly/2knidMg@EASDNews#biotech#regenerativemedicine#health#T1D#regenmed#innovationHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for a great visit! It was great to share our progress in developing a functional cure for insulin-requiring
#diabetes and to learn about your legislative priorities to support#innovation in#sandiego.#biotech#T1D#lifescienceshttps://twitter.com/RepScottPeters/status/1169691920202981379 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ViaCyte welcomes Paul J. Hastings and Ian F. Smith to the company’s Board of Directors https://viacyte.com/archives/press-releases/viacyte-to-expand-board-of-directors-with-two-new-appointments …
#biotech#health#T1D#SanDiego#businesspic.twitter.com/PDR4sgFrjX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sandra E. Poole joins ViaCyte’s Board of Directors http://bit.ly/2Nk9O9W
#biotech#health#T1D#SanDiego#diabetes#regenerativemedicine#regenmed#businesspic.twitter.com/rzzZvPZCI3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to the
@Xconomy editors and local experts who named ViaCyte and Gene Yeo@yeo_lab the 2019 “Big Idea” winners! http://bit.ly/2YXALkF#XconomyAwardsSanDiego#SanDiego#biotech#health#T1D#diabetes#regenerativemedicine#regenmed@sarahdcpic.twitter.com/rNlXztosYY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ViaCyte proslijedio/la je Tweet
And the
#XconomyAwardsSanDiego Big Idea Award winners are… Gene Yeo of@UCSanDiego and@ViaCyte!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A great round up of how ViaCyte’s breakthrough science, products and collaborations have earned the company a spot in
@Xconomy’s 2019 Awards, “Big Idea” category http://bit.ly/2wbIkrM#biotech#health#T1D#SanDiego#diabetes#regenerativemedicine#regenmed#business@sarahdcpic.twitter.com/wjy0G3z05t
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Event May 13 11AM ET/8AM PT: Join ViaCyte VP Dr. Howard Foyt and
@Covance for a webinar on “State-of-the-Art Technology for Insulin Therapy in Type 1#Diabetes: Engineering and Cell-based Approaches” http://bit.ly/2Lrqeg0#biotech#health#T1D@BRWebinarspic.twitter.com/rlVsqUfFsu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.